Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celator Pharmaceuticals says Cephalon will examine its technology
Yahoo/AP
Thursday, May 21, 2009 - 3:20pm
tags:
Celator, Cephalon
JNJ: Don't Get Fooled by Dividend Plays
Seeking Alpha
Thursday, May 21, 2009 - 3:19pm
tags:
JNJ, dividends
Drug stocks lose ground; Vical rallies on vaccine news
Marketwatch
Thursday, May 21, 2009 - 11:41am
tags:
Vical, drug stocks
[video]Mad About Options: Like a Bull in a Hospital (Biogen)
Yahoo/TheStreet.com
Thursday, May 21, 2009 - 11:39am
tags:
Biogen Idec, options
Human Genome Sciences files for approval of ABthrax, designed to treat inhaled anthrax
Yahoo/AP
Thursday, May 21, 2009 - 11:38am
tags:
Human Genome Sciences, anthrax, FDA, ABthrax
Eli Lilly starts late-stage Alzheimer's drug tests
Yahoo/AP
Thursday, May 21, 2009 - 10:50am
tags:
Eli Lilly, drug trials, Alzheimer's disease, solanezumab
Oscient fends off new patent challenge
Bizjournals.com
Thursday, May 21, 2009 - 10:31am
tags:
Oscient, patents, Antara
Barclays analyst upgrades Biogen on Tysabri
Yahoo/AP
Thursday, May 21, 2009 - 10:25am
tags:
Biogen Idec, upgrades, Tysabri
Amylin Responds to Eastbourne Letter
Yahoo
Thursday, May 21, 2009 - 10:24am
tags:
Amylin
Nexavar approved in Japan for liver cancer
Yahoo/AP
Thursday, May 21, 2009 - 10:24am
tags:
Japan, Nexavar, liver cancer, Bayer, ONYX Pharmaceuticals
Notes from BIO: Vaccine Applications to FDA Booming
InVivo
Thursday, May 21, 2009 - 10:22am
tags:
BIO, vaccines
Dr. Reddy's To Reorganize Drug-Discovery Operations
NASDAQ.com
Thursday, May 21, 2009 - 10:21am
tags:
Dr Reddy's, drug discovery
Pfizer's Kindler on Health-Care Reform and the Wyeth Deal
Businessweek
Thursday, May 21, 2009 - 6:46am
tags:
Jeff Kindler, Pharma CEOs, Pfizer, Wyeth, healthcare reform
J&J arbitrating to pull out of valuable Remicade partnership as Merck buys Schering-Plough
Yahoo/AP
Thursday, May 21, 2009 - 6:46am
tags:
JNJ, Merck, partnerships, Remicade, Schering Plough
Court Grants AstraZeneca Preliminary Injunction Against Apotex in PULMICORT RESPULES Patent Litigation
Yahoo
Thursday, May 21, 2009 - 6:45am
tags:
AstraZeneca, generics, Pulmicort
Isis and Genzyme: Clinical Trial Positive, Stock Not So Much
Motley Fool
Thursday, May 21, 2009 - 6:43am
tags:
drug trials, Isis Pharmaceuticals, Genzyme, mipomersen
PhRMA Tries to Keep ‘Comparative Effectiveness’ in Check
WSJ Online
Wednesday, May 20, 2009 - 10:20am
tags:
PhRMA, comparative effectiveness
Four biotech CEOs offer their views on key trends
Fierce Biotech
Wednesday, May 20, 2009 - 10:18am
tags:
biotech
Notes from BIO: BIO, Meet Sanofi; Sanofi, Meet BIO
InVivo
Wednesday, May 20, 2009 - 10:16am
tags:
Sanofi, BIO
AstraZeneca e-mails show debate on Seroquel risks
Yahoo/AP
Wednesday, May 20, 2009 - 10:14am
tags:
AstraZeneca, Seroquel

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.